Rheumatology

Rheumatology focuses on diagnosing and treating conditions that affect the joints, muscles, and connective tissues. Common conditions include rheumatoid arthritis, lupus, osteoarthritis, gout, and ankylosing spondylitis. These diseases can lead to chronic pain, inflammation, and reduced mobility, significantly impacting patients' quality of life. Everyday tasks can become challenging, and long-term disability is possible without effective treatment.

Current treatments often involve medications like anti-inflammatory drugs, steroids, or disease-modifying therapies to manage symptoms and slow disease progression. However, these treatments may not work for everyone, and some can have side effects. That’s why ongoing research in rheumatology is crucial.

New studies are exploring innovative therapies, such as biologics and gene therapy, aiming to improve patient outcomes and reduce side effects. 

Clinical research plays a vital role in advancing knowledge, testing new treatments, and developing more personalized care options to enhance quality of life for those affected by rheumatic diseases.

Momentum Clinical Research has been actively involved in a variety of studies aimed at advancing treatments for rheumatology conditions.These studies include investigations into oral therapies, injections, and long-term treatments designed to relieve pain, improve physical function, and address underlying disease mechanisms. The research spans conditions such as rheumatoid arthritis, osteoarthritis, and gout, with a focus on both immediate symptom relief and long-term improvements in patient health.

Recent research has included studies looking at: 

• Testing a treatment approved for multiple inflammatory conditions on adults with moderately to severely active Lupus.
• Studying an investigational oral treatment, containing cannabidiol (CBD), that is intended to relieve pain and improve physical function in adults with rheumatoid arthritis.
• Testing an investigational intra-articular (in the joint) injection that intends to decrease pain and improve physical function for adults with osteoarthritis of the knee.
• Evaluating whether a 12-month course of an investigational drug can reduce uric acid levels for people with gout and high uric acid levels.
• Testing an investigational subcutaneous (under the skin) injection that intends to treat current osteoarthritis pain, whilst also encouraging a long-term reduction of symptoms.